Amedica Corporation, a Salt Lake City, UT-based developer of innovative spine and total joint implants, has completed a $30m financing.
The financing consists of $15m in private equity and a debt facility of $15m.
Zions First National Bank provided the debt facility while Creation Capital acted as the placement agent for the private equity portion.
The proceeds from this financing will be used for expansion, mergers and acquisitions, sales and marketing support.
Commenting on the financing, Ben Shappley, CEO, President and Director of Amedica, was quoted as saying: “We are pleased to complete this transaction that will enable and further sustain our substantial growth”.
Amedica, which has already completed transactions in excess of $100m in the recent past, is an emerging orthopaedic implant company focused on using its silicon nitride ceramic and other technologies to develop and commercialize a broad range of spine and total joint implants for the growing orthopaedic device market. It has already brought to market various spinal implant products, while products under development include reconstructive hip and knee implants.
Amedica is ISO 13485 certified and its products are FDA cleared and CE approved.